AUG 31, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Cefazolin (Labeling)
U.S. Food and Drug Administration
FDA supplemental approval of labeling changes for cefazolin formulations; no clinical trial data or efficacy evidence is reported in this regulatory record.
Reported
Approval status date2026-08-31